Beta Blockers May Cause Sleep Problems, But Not Depression: Study

The side effects of beta blockers may increase the likelihood of experiencing sleep problems or having unusual dreams, according to the findings of a new study. However, the drugs do not appear to increase the risk of depression, which has been a concern highlighted in earlier research.

In a report published this week in the medical journal Hypertension, German researchers evaluated the psychiatric impact of beta blockers, which includes brand name medications like Lopressor, Normodyne, Tenormin, and InnoPran XL.

The drugs are commonly used to treat cardiovascular diseases, including heart failure, chest pain, high blood pressure and abnormal heart rhythm. Prior studies have suggested the medications may cause a number of side effects, including depression, anxiety, drowsiness, insomnia, hallucinations and nightmares. However, while the new findings do indicate the medications cause sleep disturbances, depression did not occur more commonly when compared to use of a placebo.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Researchers used data from 285 eligible studies, including more than 53,000 patients. Most of the studies used were double-blind, randomized controlled trails, primarily focusing on high blood pressure treatment. Of those, 31 studies assessed depression in placebo-controlled trials.

The new findings appear to contradict prior research that has suggested a link between depression and beta blockers.

Researchers indicate drugs like Lopessor and Normodyne do not increase the risk of depression or withdrawal for depression. However, the new study did find a link between taking beta blockers and patients having unusual dreams, insomnia, and sleep disturbances.

This is an analysis of large scale data from double blind randomized controlled trials. Researchers said the findings are compelling because double-blind randomized controlled trials are used to prove cause-and-effect, compared to large retrospective studies which only indicate an association.

“(N)o effect for beta blockers was found for other psychiatric adverse events, with the possible exceptions of sleep-related disorders,” the researchers concluded. “Consequently, concerns about beta blockers’ impact on psychological health should not affect their use in clinical practice.”

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted today)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted yesterday)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).